Mechanisms of the cerebral vasodilator actions of isoflavonoids of Gegen on rat isolated basilar artery

• Published in: Journal of ethnopharmacology Vol. 139; no. 1; pp. 294 - 304
• Main Authors: Deng, Y., Ng, E.S.K., Yeung, J.H.K., Kwan, Y.W., Lau, C.B.S., Koon, J.C.M., Zhou, L., Zuo, Z., Leung, P.C., Fung, K.P., Lam, F.F.Y.
• Format: Journal Article
• Language: English
• Published: Ireland Elsevier Ireland Ltd 06-01-2012
• Subjects: Animals; Arteries; barium; Basilar artery; Basilar Artery - drug effects; Basilar Artery - physiology; calcium; Calcium - physiology; calcium chloride; Calcium influx; Cardiovascular diseases; Cerebrovascular diseases; cerebrovascular disorders; Chloride; Daidzein; Daidzin; Drugs, Chinese Herbal - isolation & purification; Drugs, Chinese Herbal - pharmacology; Endothelium; Enzymes; Flavonoids - isolation & purification; Flavonoids - pharmacology; Flurbiprofen; Gegen; glibenclamide; guanylate cyclase; In Vitro Techniques; inhibitory concentration 50; Isoflavonoid; isoflavonoids; Male; Muscle contraction; myocytes; NG-Nitroarginine methyl ester; nitric oxide; Nitric Oxide - physiology; Nitric-oxide synthase; Oriental traditional medicine; Plant Roots; potassium; Potassium channels; Potassium Channels - physiology; Pueraria; Pueraria lobata; Pueraria montana var. lobata; Puerarin; Rats; Rats, Sprague-Dawley; smooth muscle; Tetraethylammonium; Traditional Chinese Medicine; Vasodilation; Vasodilation - drug effects; Vasodilator Agents - isolation & purification; Vasodilator Agents - pharmacology; Vasodilators; Basilar artery; Daidzin; Daidzein; Isoflavonoid; Puerarin; Gegen
• ISSN: 0378-8741; 1872-7573
• DOI: 10.1016/j.jep.2011.11.021

Gegen (root of Pueraria lobata) is used in traditional Chinese medicine for treatment of cardiovascular diseases. In this study, the relaxant actions of three of its isoflavonoids; puerarin, daidzein, and daidzin, were investigated on rat-isolated cerebral basilar artery.
Rat basilar artery rings were precontracted with 100nM U46619. Involvement of endothelium-dependent mechanisms was investigated by mechanical removal of the endothelium and inhibitors of nitric oxide synthase (NOS) and cyclooxygenase (COX) enzymes. Adenylyl cyclase- and guanylyl cyclase-dependent pathways were investigated using their respective inhibitors 9-(tetrahydro-2-furanyl)-9H-purine-6-amine (SQ22536) and 1H-[1,2,4]oxadiazolo [4,3-[alpha]]-quinoxalin-1-one (ODQ). K+ channels were investigated by pretreatment of the artery rings with various K+ channel inhibitors, and Ca2+ channels were investigated in artery rings incubated with Ca2+-free buffer and primed with 100nM U46619 for 5min prior to adding CaCl2 to elicit contraction.
Puerarin, daidzein, and daidzin produced concentration-dependent relaxation of the artery rings with concentration that produced 50% inhibition (IC50) of 304±49μM, 20±7μM, and 140±21μM, respectively. Removal of the endothelium produced no change on their vasorelaxant responses except the maximum response (Imax) to puerarin was inhibited by 28%. The NOS inhibitor NG-nitro-l-arginine methyl ester (L-NAME; 100μM) also produced 45% inhibition on the puerarin-induced vasorelaxant response, but not the COX inhibitor flurbiprofen (10μM). SQ22536 (100μM) and ODQ (100μM) did not affect the vasodilator responses to puerarin, daidzein and daidzin, but glibenclamide (1μM), tetraethylammonium (TEA, 100mM) or a combination of K+ channel inhibitors (100nM iberiotoxin+1mM 4-aminopyridine+100μM barium chloride+1μM glibenclamide+100mM TEA) reduced their Imax. The contractile response to CaCl2 was attenuated by 61% and 34% in the presence of daidzein and daidzin, respectively, whereas, puerarin did not significantly affect the contraction.
The vasorelaxant action of daidzein and daidzin involved opening of K+ channels and inhibition of Ca2+ influx in the vascular smooth muscle cells. There is no evidence supporting involvement of endothelium-derived relaxing factors (EDRFs) in their actions. In contrast, puerarin produced vasodilatation via an endothelium-dependent mechanism involving nitric oxide production and an endothelium-independent pathway mediated by the opening of K+ channels. The cerebral vasodilator activities of all these three isoflavonoids may be beneficial to patients with obstructive cerebrovascular diseases.